Literature DB >> 405166

Levamisole augments the cytotoxic T-cell response depending on the dose of drugs and antigen administered.

R B Faanes, P Dillon, Y S Choi.   

Abstract

The effects of levamisole on the immune of cytotoxic thymus-derived lymphocytes were studied. An optimum relative dose of antigen and and lavamisole appears to be crucial for levamisole to augment development of cytotoxic cells.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 405166      PMCID： PMC1540944     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


  15 in total

1.  Characterization of the immunostimulants levamisole and tetramisole.

Authors:  F Spreafico; A Vecchi; A Mantovani; A Poggi; G Franchi; A Anaclerio; S Garattini
Journal:  Eur J Cancer       Date:  1975-08       Impact factor: 9.162

2.  Modulation of immune reactivity by phenylimidothiazole salts in mice immunized by sheep red blood cells.

Authors:  G Renoux; M Renoux
Journal:  J Immunol       Date:  1974-09       Impact factor: 5.422

3.  Levamisole inhibits and cures a solid malignant tumour and its pulmonary metastases in mice.

Authors:  G Renoux; M Renoux
Journal:  Nat New Biol       Date:  1972-12-13

4.  Levamisole inactive in treatment of four animal tumours.

Authors:  C W Potter; I Carr; R Jennings; R C Rees; F McGinty; V M Richardson
Journal:  Nature       Date:  1974-06-07       Impact factor: 49.962

5.  Augmentation of chemotherapeutically induced remission of a murine leukemia by a chemical immunoadjuvant.

Authors:  M A Chirigos; J W Pearson; J Pryor
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

6.  Corynebacterium parvum as a therapeutic antitumor agent in mice. I. Systemic effects from intravenous injection.

Authors:  M T Scott
Journal:  J Natl Cancer Inst       Date:  1974-09       Impact factor: 13.506

Review 7.  Cell-mediated cytotoxicity, allograft rejection, and tumor immunity.

Authors:  J C Cerottini; K T Brunner
Journal:  Adv Immunol       Date:  1974       Impact factor: 3.543

8.  [Immunostimulating action of phenylimidothiazole derivatives on spleen antibody-producing cells].

Authors:  G Renoux; M Renoux
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1972-01-31

9.  Modulating effects of levamisole (NSC-177023) on human lymphocyte response in vitro.

Authors:  J L Lichtenfeld; M R Desner; P H Wiernik; M R Mardiney
Journal:  Cancer Treat Rep       Date:  1976-05

10.  Restoration of cell-mediated immunity to animals blocked by a humoral response.

Authors:  G B Mackaness; P H Lagrange
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307
View more
  1 in total

1.  The antitumour activity of maltose tetrapalmitate compared with other immunoadjuvants, and its effectiveness after tumour surgery.

Authors:  H El Kappany; C Chopra; V N Nigam; C A Brailovsky; M Elhilali
Journal:  Br J Cancer       Date:  1980-11       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.